QCLS

Conviction 19HealthcareScan · Thu, Jun 25, 2026

QCLS$3.71-2.62%

ResistanceSupportVol 14

Vol MA14 312.19K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Q/C TECHNOLOGIES, INC.IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.qctechnologies.com ↗

Price3.71

Change-2.62%

Gap+3.67%

Rel volume1.40×

Avg volume362.77K

Avg $ vol1.46M

SMA 203.95

SMA 503.94

SMA 200—

Price vs 50-5.73%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 3.54

RSI (14)44

MACD hist-0.02

MACD crossbear · 1d

Stoch %K / %D27 / 39

ADX (14)26

+DI / −DI19 / 15

RSI divergence—

MACD divergence—

ATR %+8.91%

ADR %8.21%

52w high6.92

52w low2.76

From 52w high-46.39%

Above 52w low+34.66%

New 52w highNo

SqueezeOff

Bollinger width25.45%

%B0.26

Donchian pos15.50%

Donchian high4.80

Donchian low3.51

AVWAP (52w high)5.24

vs AVWAP high-29.21%

AVWAP (52w low)5.60

vs AVWAP low-33.80%

OBV trendDown

Chaikin MF (20)-0.07

Today vs 20d1.40×

Avg vol (14d)312.19K

Avg vol (20d)362.77K

Avg $ vol (20d)1.46M

Market cap29.14M

RS 3m (vs SPY)-9.28%

RS 6m (vs SPY)-29.66%

RS line new highNo

Trend template—

Technical rank20.0

1 week-3.89%

1 month-5.84%

3 months-2.37%

6 months-31.80%

1 year—

YTD-12.29%

P/E-2.51

P/B1.41

P/S18.48

P/FCF-3.19

EPS-8.66

Div yield—

ROE-56.12%

ROA-30.36%

Debt/Eq0.01

Current3.71

EV/EBITDA-2.88

Gross margin30.36%

Net margin-737.28%

Rev growth-5.32%

EPS growth50.22%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value28.32M

Revenue-1.89K

Net income-1.24M

Gross profit-379.06K

Free cash flow-9.13M

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNasdaq

Shares out7.85M

Employees2

ListedMon, Apr 19, 2021

Free float7.79M

Float %99.2%

Short interest1.63M

Days to cover2.7d

Short volume51.4%

Squeeze score67 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction19 / 100

Pattern quality—

Tech rank20.0 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.15

Support3.59

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QCLS

All disclosures →

No recent disclosed trades by Congress in QCLS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QCLS

No recent insider (Form 4) filings in QCLS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in QCLS

EDGAR →

No recent SEC filings on file for QCLS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.